• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR RX HERCULINK ELITE STENT SYSTEM; STENT, RENAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR RX HERCULINK ELITE STENT SYSTEM; STENT, RENAL Back to Search Results
Catalog Number UNK HERCULINK ELITE
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Intimal Dissection (1333); Occlusion (1984)
Event Date 01/01/2017
Event Type  Injury  
Manufacturer Narrative
Dates of event and implant: estimated dates.Unique device identifier (udi#): in the absence of a reported part number, the udi cannot be calculated.The device was not returned for analysis.The lot history record (lhr) for this product could not be reviewed because the part and lot numbers were not reported.The reported patient effects of dissection and occlusion are listed in the herculink elite instruction for use as known potential patients effects associated with the use of a stent in peripheral arteries and / or biliary tree.Based on the case information, a conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.The additional therapy/non-surgical treatment surgical procedure, and hospitalization were likely related to case circumstances.There is no indication of a product quality issue with respect to manufacture, design or labeling.Article titled: ¿herculink elite post market clinical follow-up report." the additional adverse patient effect of death referenced is being filed under a separate medwatch report#.
 
Event Description
It was reported through a research article identifying herculink elite stents that may be related to the following: death, target lesion dissection, unplanned amputation, occlusion, intervention re-treatment, and surgical re-treatment.Details are listed in the article, titled ¿herculink elite post market clinical follow-up report.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RX HERCULINK ELITE STENT SYSTEM
Type of Device
STENT, RENAL
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 2024168
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key10590830
MDR Text Key208722181
Report Number2024168-2020-08037
Device Sequence Number1
Product Code NIN
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P110001
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type literature
Reporter Occupation Physician
Type of Report Initial
Report Date 09/25/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/25/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK HERCULINK ELITE
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/04/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention; Disability;
-
-